Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What a s***** job. Any one of us here could have done better than that.
You want to get as much time as you can and it's not that expensive. It's not that expensive at all and it gives me plenty of time.
I was looking at the January 21st 2022 $25. What do you think about that?
I haven't had a chance to look at the options. But it's obvious you have which ones you like the best?
geomagnetic unrest ?
Has to be a joke.....
It better have been blue, double yolk of course.
This is crazy, 7000 shares on the open and 5 minutes into trading with almost a 20 cent spread.
They already have, it's chicken soup.
The short position is becoming a most dubious place to be.
Seems to me, shorts will be crushed unless protection is in place. By the way it's a rising tide.
On average, a drug in an expedited program reaches market almost a year sooner than other drugs.
You got me out of bed with this post.
Appreciate it.
Great job!
The Ameraucana is beloved for its' light blue eggs. It is a moderately good layer, producing about 3–4 medium-sized eggs/week. It can be a bit of a late starter, so don't expect your eggs at 18-20 weeks.
Blue-
Now that just might be some good solid sarcasm. You can always get a great chuckle out of that egg laying genius. Just don't expect any extra large. You just gotta love him.
What does it mean when a chicken cackles ?
You might hear light, quiet peeps or trills. Soft warbling sounds are also common. All of these noises are good and are exactly what you want to hear. These noises simply mean that your chickens are contented and happy.
We didn't go over 27 and I'm a little bit disappointed, however, I love that turn and it won't be long before the sellers are gone.
$27.02 unlikely not to be broken today.
Looks like the stock will be moving on liquidity or lack of.
Downside is very limited and I expect some more option play.
With the futures like there are we should have no problem today.
So everybody let's just have a great day.
That's going to happen somewhere in here and most likely pretty soon.
I see a pop into the $30 range.
The Current Price Range Based on 1 Vendors on Bimedis. It's Costs Starts Approximately at $32,995 and ends at the Highest Price $32,995. The Average Price for TECAN Freedom EVO 200 - $24,377 Based on 5 Listings of This Product
lenzilumab in the ACTIV -5 Trial sponsored by NIAID, and the ... Prevention/Treatment of Acute GvHD ... Cost of care is estimated at ~$13K per day for a hospitalized.
I got a quote from a lab in New York on the gram of lenzilumab to be sold for testing.
50k
Is that right?
Congratulations are in order.
It's been a hell of a long journey I bet.
If I was in your position,, I keep what I had and look for something else that's going to go up 500% in a year and a few months.
What I'm doing is I'm adding HGEN. Mind you, I haven't sold any shares of Avid.
It's not as much fun to watch as avid right now, but i I believe it will be in a few months.
ISINUS05368M1062LEI549300GRUS3ZMGP8MX22
Institutional Owners360 total, 352 long only, 6 short only, 2 long/shortShares
Outstanding60,828,589 shares
Institutional Shares56,572,206 - 93.00% (ex 13D/G)
Institutional Value$ 1,106,558 USD ($1000)
Margins are still weak, but improving. We need to get to 40% with industry standards are.
Seems to me like the driving force is the number of customers.
I'm almost certain that I'll build out will be brought to capacity.
Weebles wobble but they don't fall down. Very difficult for this stock to move in a negative direction with all the institutional buyers covering 90 plus percent of the float.
You're absolutely right. I couldn't ask for a better CEO.
You have no worries. We will beat on revenue and be on eps. I'm looking for a $10 million beat on revenue and 3 cents per share per share eps
I been in the right place
But it must have been the wrong time
I'd have said the right thing
But must have used the wrong line
I been on the right trip
But I must have used the wrong car
Head is in a bad place and I wonder what it's good for
I been in the right place
But it must have been the wrong time
My head is in a bad place
But I'm having such a good time
I been running trying to get hung up in my mind
Really got to give myself a good talking to this time
Just need a little brain salad surgery
Got to que my insecurity
I been in the wrong place
But it must have been the right time
I been in the right place
But it must have been the wrong song
I been in the right vein
But it seems like a wrong arm
I been in the right world
But it seems like wrong-wrong-wrong…
Being from New Orleans, and to see your screen name with your message, I just had to......
Where did we go from here is your question.
We have a great product, we have the technical know-how, and it seems like we're one of the best in the business. This is not something you can duplicate with just throwing cash at it. You need time and expertise.
Valuation on this type of company requires a certain premium. Valuation is going to depend on what somebody is willing to pay.
One thing is for certain to me, it's going to be in the billions, and not just one or two.
Good Job on the post!
We need margins moving up, and approaching 40%.
The build-out, and the plans for the $100 million plus.
I'll be surprised if we don't have a solid beat on numbers.
Cheers...
All we need is a few more pennies to make an all-time high and a new 52-week high.
It's going to happen . And you can take that to the bank.
Cheers!
What's going to happen is we're going to beat substantially and he's going to raise his price Target.
By then they should have gotten their load.
All aboard !
And this:
Avid”) and Humanigen, Inc. (NASDAQ:HGEN) (“Humanigen”) today announced that they have entered into a manufacturing services agreement to expand production capacity for lenzilumab™, Humanigen’s therapeutic candidate in development for COVID-19. Lenzilumab is an anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody designed to prevent and treat an immune hyper-response called “cytokine storm” associated with COVID-19. Humanigen has completed enrollment of its 520 patient Phase 3 clinical trial of lenzilumab in hospitalized COVID-19 patients.
How we going to have a whisper miss.......
We will beat on revenue and eps substantially.
I believe we've had to have gotten upfront money from this:
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it will serve as the commercial manufacturer for the humanized monoclonal antibody portion of ZYNLONTA™ (loncastuximab tesirine-lpyl), a recently approved cancer treatment developed by ADC Therapeutics SA (NYSE: ADCT). Avid has provided clinical manufacturing services to ADC Therapeutics to support development of the product since 2017 and will now expand its manufacturing relationship with ADC Therapeutics to include commercial manufacturing activities for ZYNLONTA.
I believe it's more he looks like a fool with the price being 25 and his Target being 21 or 22.
It seems to me that anyone with a twenty one price Target should be shorting by now.
Those butt plugs they call analyst are stunningly and embarrassingly completely full of manure.
And if they have information that's not in the public domain then they have no right to give any kind of price Target with that information.
It's more likely he doesn't want to look like a fool.
Based on what?
What new information does he have, and why would he raise it right before earnings?
I'd hate to tell you how many of these yoyos I've gotten on the phone and had discussions with. Oh yes, they had their metrics. Worked out perfectly. To me, it always seems like agenda driven BS. based on what they want their position to do.
Once in awhile you get an honest hard-working guy from a major investment firm but next time you check he's out the door.
Here's my agenda driven Price Target, 45 to 50 by the end of the year. Now of course, I'll adjust everything after I see the new numbers and the conference call. I would never do this going nto a CC.
What I'm looking for and at to keep my price Target.
Margins and growth.
Based on current price targets, I'm seeing no action on the latest price targets. It seems like the Fermi paradox has hit home. Based on latest Target prices from the analyst we ought to see a lot of shorting
I don't see the shorts piling in anywhere. I guess we need to build some bigger telescopes and send out a lot more probes.
I have a little doubt, and I've been right so far. Nobody believed it when I started talking.
So the question is where do we go from here?
The earnings really don't matter that much.
What matters is how fast the buildout is going what do we look like on sales, and what's going on with that hundred +, million.
I Believe by the end of the year we're going to be 45 Plus.
We just hit the high for the day and it looks like it's just getting started, come on let's break through that 25 this week.
I certainly believe we were going higher. Everything is hitting the ask.
Hardly ever do you see buying like this right before earnings. I guess we have some spectacular news coming out.
There seems to be some buying going on. I believe we're going higher.
Back in the day they used to say, I'm extremely bullish on avid biosciences.